SIREN : 808214407
MAPAXE is a French company founded 11 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BAYONNE (64100), this company of category PME shows in 2022 a revenue of 1.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | 1 383 312 € | N/C | N/C | N/C | N/C | 1 087 211 € |
| Net income | 93 244 € | 27 922 € | 44 568 € | 60 981 € | 74 946 € | 66 469 € | 81 182 € | 81 812 € | 106 541 € |
| EBITDA | N/C | N/C | N/C | 136 599 € | N/C | N/C | N/C | N/C | 168 176 € |
| Net margin | N/C | N/C | N/C | 4.4% | N/C | N/C | N/C | N/C | 9.8% |
In 2024, MAPAXE generates positive net income of 93 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 107 k€ -> 93 k€.
93 244 €
The debt ratio (= Financial debt / Equity x 100) stands at 83%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 46%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
82.58%
46.43%
42.7%
In 2024, the debt ratio of MAPAXE (82.58) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of MAPAXE (46.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
The liquidity ratio (= Current assets / Current liabilities) stands at 106.29. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
106.288
In 2024, the liquidity ratio of MAPAXE (106.29) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 225 transactions of similar company sales in 2024, the value of MAPAXE is estimated at 1 301 755 € (range 906 521€ - 1 947 500€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare MAPAXE with other companies in the same sector:
The revenue of MAPAXE in 2022 is 1.4 M€.
Yes, MAPAXE generated a net profit of 93 k€ in 2024.
The headquarters of MAPAXE is located in BAYONNE (64100), in the department Pyrenees-Atlantiques.
The tax return of MAPAXE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
MAPAXE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.